Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.
Poeppel TD, Handkiewicz-Junak D, Andreeff M, Becherer A, Bockisch A, Fricke E, Geworski L, Heinzel A, Krause BJ, Krause T, Mitterhauser M, Sonnenschein W, Bodei L, Delgado-Bolton RC, Gabriel M. Poeppel TD, et al. Eur J Nucl Med Mol Imaging. 2018 May;45(5):824-845. doi: 10.1007/s00259-017-3900-4. Epub 2017 Dec 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 29234845 Free article.
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy.
Syguła A, Ledwon A, Hasse-Lazar K, Jurecka-Lubieniecka B, Michalik B, Paliczka-Cieślik E, Zeman M, Chmielik E, Sczasny J, Jarzab B, Handkiewicz-Junak D. Syguła A, et al. Among authors: handkiewicz junak d. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3841-3851. doi: 10.1007/s00259-022-05792-y. Epub 2022 May 3. Eur J Nucl Med Mol Imaging. 2022. PMID: 35503379 Clinical Trial.
EANM procedure guidelines for therapy of benign thyroid disease.
Stokkel MP, Handkiewicz Junak D, Lassmann M, Dietlein M, Luster M. Stokkel MP, et al. Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2218-28. doi: 10.1007/s00259-010-1536-8. Epub 2010 Jul 13. Eur J Nucl Med Mol Imaging. 2010. PMID: 20625722
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma.
Krajewska J, Jarzab M, Kukulska A, Czarniecka A, Roskosz J, Puch Z, Wygoda Z, Paliczka-Cieslik E, Kropinska A, Krol A, Handkiewicz-Junak D, Jarzab B. Krajewska J, et al. Nucl Med Mol Imaging. 2019 Oct;53(5):320-327. doi: 10.1007/s13139-019-00608-8. Epub 2019 Sep 5. Nucl Med Mol Imaging. 2019. PMID: 31723361 Free PMC article.
85 results